Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Pharmaceutics|August 12, 2023
A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysisXiaoxu Li, Ximing Pu, Xingming Wang, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|February 27, 2010
Synthesis and characterization of novel multiphase bioactive glass-ceramics in the CaO-MgO-SiO(2) systemXianchun Chen, Xiaoming Liao, Zhongbing Huang, et al.
The Journal of Organic Chemistry|February 17, 2023
PPh3-Mediated Cascade Reaction of 2-Alkynylnitrobenzenes and Thioureas for the Construction of Imidazo[4,5-b]indole-2-thionesYao Xu, Hui Fan, Fan Yang, et al.
Materials (Basel, Switzerland)|August 26, 2018
Synthesis of Macroporous Magnetic Fe₃O₄ Microparticles Via a Novel Organic Matter Assisted Open-Cell Hollow Sphere Assembly MethodHuixia Wang, Ximing Pu, Yaquan Zhou, et al.
RSC Advances|May 11, 2022
MoO3- -deposited TiO2 nanotubes for stable and high-capacitance supercapacitor electrodesShupei Sun, Yu Sun, Jiang Wen, et al.
RSC Advances|May 11, 2022
Thermosensitive star polymer pompons with a core-arm structure as thermo-responsive controlled release drug carriersNa Xu, Xiaobei Huang, Guangfu Yin, et al.
Journal of Colloid and Interface Science|July 25, 2008
Preparation and characterization of the biomineralized zinc oxide particles in spider silk peptidesZhongbing Huang, Danhong Yan, Mei Yang, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|July 24, 2012
[Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma]Minping Bi, Dinghua Yang, Xianghong Li, et al.
Nanotechnology|February 28, 2024
Ratiometric fluorescence detection of dopamine based on copper nanoclusters and carbon dotsZhihan Meng, Shupei Sun, Ximing Pu, et al.
Oncotargets and Therapy|June 30, 2016
Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancerMinmin Zhang, Wei Wei, Jianlun Liu, et al.
Pageof 10